Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?

Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force

(2013) Roger Chou et al.   ANNALS OF INTERNAL MEDICINE

Complications following prostate needle biopsy requiring hospital admission or emergency department visits - experience from 1000 consecutive cases

(2012) G. Igor Pinkhasov et al.   BJU INTERNATIONAL

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Screening for Prostate Cancer With Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion

(2012) Ethan Basch et al.   JOURNAL OF CLINICAL ONCOLOGY

PCA3 sensitivity and specificity for prostate cancer detection in patients with abnormal PSA and/or suspicious digital rectal examination. First Latin American experience

(2012) Christian G. Ramos et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range

(2011) William J. Catalona et al.   JOURNAL OF UROLOGY

Morbidity Of Prostate Biopsy After Simplified Versus Complex Preparation Protocols: Assessment of Risk Factors

(2011) Osama M. Zaytoun et al.   UROLOGY

Biopsy and treatment decisions in the initial management of prostate cancer and the role of PCA3; a systematic analysis of expert opinion

(2011) Bertrand Tombal et al.   WORLD JOURNAL OF UROLOGY

A Prospective, Multicenter, National Cancer Institute Early Detection Research Network Study of [-2]proPSA: Improving Prostate Cancer Detection and Correlating with Cancer Aggressiveness

(2010) L. J. Sokoll et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

PCA3: From basic molecular science to the clinical lab

(2010) John R. Day et al.   CANCER LETTERS

Rational approach to implementation of prostate cancer antigen 3 into clinical care

(2009) Rou Wang et al.   CANCER

Validation in a Multiple Urology Practice Cohort of the Prostate Cancer Prevention Trial Calculator for Predicting Prostate Cancer Detection

(2009) Stephen J. Eyre et al.   JOURNAL OF UROLOGY

Prostate Specific Antigen Best Practice Statement: 2009 Update

(2009) Kirsten L. Greene et al.   JOURNAL OF UROLOGY

Mortality Results from a Randomized Prostate-Cancer Screening Trial

(2009) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy

(2008) Alexander Haese et al.   EUROPEAN UROLOGY

PCA3 Molecular Urine Assay Correlates With Prostate Cancer Tumor Volume: Implication in Selecting Candidates for Active Surveillance

(2008) Hiroyuki Nakanishi et al.   JOURNAL OF UROLOGY

PCA3: A Molecular Urine Assay for Predicting Prostate Biopsy Outcome

(2008) Ina L. Deras et al.   JOURNAL OF UROLOGY

Conditional estimation of sensitivity and specificity from a phase 2 biomarker study allowing early termination for futility

(2008) Margaret Sullivan Pepe et al.   STATISTICS IN MEDICINE